TNF and Skin rash: Patient 2 had partial responses to colchicine, but recurrence of rash, fatigue, and systemic inflammation led to empiric treatment with the TNF inhibitor etanercept at the age of 14, which rapidly improved skin rashes, normalized acute phase reactants, and led to long-term remission (Fig. 4a).